Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Rae

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Breast Cancer Research and Treatment|May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Clinical Breast Cancer|April 1, 2019
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways StudyVictoria Larsen, William E Barlow, Jun J Yang, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Cancer Research|December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCostanza Paoletti, Andi K Cani, Jose M Larios, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Breast Cancer Research and Treatment|May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Clinical Breast Cancer|April 1, 2019
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways StudyVictoria Larsen, William E Barlow, Jun J Yang, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Cancer Research|December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCostanza Paoletti, Andi K Cani, Jose M Larios, et al.
Pageof 13